title: Inhibition of high glucose-induced protein mono-ADP-ribosylation restores neuritogenesis and sodium-pump activity in SY5Y neuroblastoma cells.
abstract: The exposure of SY5Y neuroblastoma cells to high concentrations of glucose, fructose, or galactose is an experimental model commonly used for in vitro evaluation of typical neuronal alterations observed in diabetes mellitus. In the present study, we observed that 2 weeks of exposure to high carbohydrate concentrations caused both a significant impairment in neurite formation induced by supplementation of retinoic acid or by subtraction of fetal calf serum to the culture medium and a marked reduction in Na(+)-K(+)-ATPase activity. However, only the exposure to high millimoles of glucose caused an enhancement of mono-ADP-ribosylation, typical of diabetes mellitus, affecting at least five proteins. The concomitant exposure to high glucose and to silybin, a mono-ADP-ribosylation inhibitor, normalized the extent of ADP-ribosylation of the five proteins and counteracted the inhibitory effects of high glucose on Na(+)-pump activity and on neuritogenesis. Conversely, the supplementation of silybin did not prevent fructose and galactose inhibitory effects on Na(+)-pump activity and neurite formation. These data confirm those of previous reports suggesting a link between excessive protein mono-ADP-ribosylation and the onset of diabetic complications such as diabetic neuropathy.
authors.affiliation: Laboratory for Research on Dysmetabolic Disorders, Pharmacological Laboratories, Department of Medicine, Surgery and Odontoiatry, H.S. Paolo, Faculty of Medicine, University of Milan, Italy.
authors.forename: A M
authors.initials: AM
authors.lastname: Di Giulio
authors.forename: E
authors.initials: E
authors.lastname: Lesma
authors.forename: E
authors.initials: E
authors.lastname: Germani
authors.forename: A
authors.initials: A
authors.lastname: Gorio
mesh_terms: D000246:Adenosine Diphosphate Ribose / Q000378:metabolism*; D016895:Culture Media, Serum-Free; D003920:Diabetes Mellitus / Q000378:metabolism; D005947:Glucose / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D009243:NAD / Q000378:metabolism; D016501:Neurites / Q000187:drug effects / Q000502:physiology*; D009447:Neuroblastoma; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism*; D014212:Tretinoin / Q000494:pharmacology; D014407:Tumor Cells, Cultured
chemical_list: D016895:Culture Media, Serum-Free; D009243:NAD; D000246:Adenosine Diphosphate Ribose; D014212:Tretinoin; D000254:Sodium-Potassium-Exchanging ATPase; D005947:Glucose